| Date | Time | Source | Headline | Symbol | Company |
| 02/09/2018 | 9:13AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 11/07/2017 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 11/07/2017 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 11/07/2017 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 11/07/2017 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 11/07/2017 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 11/07/2017 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 11/07/2017 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 11/07/2017 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 11/07/2017 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 11/07/2017 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:27PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:26PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:25PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:25PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:25PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:25PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:25PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:25PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:25PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:24PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:24PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:24PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:24PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:23PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:22PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 3:22PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 1:20PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 1:20PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |
| 10/31/2017 | 1:20PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCLN | Sciclone Pharmaceuticals, Inc. |